Kabra Drugs is not listed on NSE
AnnouncementsKabra Drugs fixes book closure for AGM
52 Week HighKabra Drugs has hit a 52wk high of Rs 16.40 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 16.05 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 15.96 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 15.78 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 15.58 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 15.28 on BSE
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.36||2545.00||1764.00||41,197.31|
|Jun' 13||Mar' 13||Dec' 12||Sep' 12|
|No Mutual Funds Holding the share|
Kabra Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4.45 crore.The company has reported a standalone sales of Rs 2.58 crore and a Net Profit of Rs 0.07 crore for the quarter ended Jun 2013.
The company management includes Shyam Kabra - Chairman & Managing Director, Madhusudan Sharma - Director, Rajendra Boardia - Director, Mahendra Mandloi - Director.
It is listed on the BSE with a BSE Code of 524322.
Its Registered office is at Plot No.26, Sanwer Road,,Sector A, Indore,Madhya Pradesh - 452003.
Their Registrars are Ankit Consultancy Pvt. Ltd.